The global pharma industry experienced a 32% rise in social media posts on artificial intelligence in Q1 2023 compared with the previous quarter, with the highest share accounted for Healthcare Information and Management Systems Society, according to GlobalData’s analysis of social media posts. Artificial Intelligence is among the top emerging technologies being employed for drug discovery and development and has demonstrated strong potential in the Pharmaceutical sector. GlobalData’s Artificial Intelligence (AI) in Drug Discovery Market – Thematic Research report provides detailed understanding of key trends, industry analysis, AI specialists in drug discovery. Buy the report here.
Notably, Covid-19 was one of the most frequently referenced themes in Q1 2023, ranking highest in terms of mentions ahead of innovation and artificial intelligence, according to GlobalData.
Of the 50 leading companies in the pharma industry, Healthcare Information and Management Systems Society had the most mentions of artificial intelligence in Q1 2023. GlobalData identified 1,398 artificial intelligence-related posts in the industry's social media activity - 0.09% of all posts - and an increase of 32% in Q1 2023 compared with Q4 2022.
To further understand GlobalData's analysis on Artificial Intelligence (AI) in Drug Discovery Market - Thematic Research buy the report here.